KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Operating Margin (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Operating Margin for 17 consecutive years, with 17.15% as the latest value for Q4 2025.

  • Quarterly Operating Margin fell 2589.0% to 17.15% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.83% through Dec 2025, down 865.0% year-over-year, with the annual reading at 1.83% for FY2025, 865.0% down from the prior year.
  • Operating Margin for Q4 2025 was 17.15% at Bio-Rad Laboratories, down from 10.0% in the prior quarter.
  • The five-year high for Operating Margin was 20.99% in Q3 2021, with the low at 17.15% in Q4 2025.
  • Average Operating Margin over 5 years is 11.93%, with a median of 13.89% recorded in 2022.
  • The sharpest move saw Operating Margin soared 779bps in 2021, then tumbled -2589bps in 2025.
  • Over 5 years, Operating Margin stood at 16.09% in 2021, then increased by 1bps to 16.25% in 2022, then dropped by -14bps to 13.99% in 2023, then tumbled by -38bps to 8.73% in 2024, then plummeted by -296bps to 17.15% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 17.15%, 10.0%, and 11.83% for Q4 2025, Q3 2025, and Q2 2025 respectively.